Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S188-S195

  Groome, Michelle J ^a,b,c   Zell, Elizabeth R ^d   Solomon, Fatima ^a,b   Nzenze, Susan ^a,b   Parashar, Umesh D ^e   Izu, Alane ^a,b   Madhi, Shabir A ^a,b,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Vaccine Preventable Diseases   (Canada)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d Stat Epi Assoc Inc   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f National Institute for Communicable Diseases A Division of National Health Laboratory Service Centre for Vaccines and Immunology   (United Kingdom)

Author keywords

children; diarrhea; HIV; rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

ARTICLE; AUTUMN; CHILD; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-10; IMMUNIZATION; INCIDENCE; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SEASONAL VARIATION; SOUTH AFRICA; UNIVERSITY HOSPITAL; WINTER; COMPLICATION; DIARRHEA; FEMALE; IMMUNOLOGY; MALE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; ROTAVIRUS INFECTIONS; SEASON; STATISTICS AND NUMERICAL DATA; TRENDS; VACCINATION; VIROLOGY;

CHILD, PRESCHOOL; DIARRHEA; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEASONS; SOUTH AFRICA; VACCINATION; VACCINES, ATTENUATED;

EID: 84965111268     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1204     Document Type: Article

References (29)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41.
2. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405-16.
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
5. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
6. Rha B, Tate JE, Payne DC, et al. Effectiveness and impact of rotavirus vaccines in the United States-2006-2012. Expert Rev Vaccines 2014; 13:365-76.
7. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(1 suppl):S6-10.
8. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 2011; 30(1 suppl):S11-5.
9. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305.
10. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
11. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
12. Groome MJ, Page N, Cortese MM, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: A case-control study. Lancet Infect Dis 2014; 14:1096-104.
13. Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and casecontrol study. Lancet Infect Dis 2015; 15:422-8.
14. Msimang VM, Page N, Groome MJ, et al. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J 2013; 32:1359-64.
15. Enweronu-Laryea CC, Boamah I, Sifah E, Diamenu SK, Armah G. Decline in severe diarrhea hospitalizations after the introduction of rotavirus vaccination in Ghana: A prevalence study. BMC Infect Dis 2014; 14:431.
16. Groome MJ, Madhi SA. Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine. Vaccine 2012; 30(suppl 1): A173-8.
17. Actuarial Society of South Africa (ASSA). AIDS and demographic model 2008. Available at: http://aids.actuarialsociety.org.za. Accessed 22 July 2015.
18. National Department of Health, South Africa. The national antenatal sentinel HIV and syphilis prevalence survey, South Africa. 2011. Available at: http://www.health.gov.za/index.php/2014-03-17-09-09-38/reports/category/99-2013re. Accessed 13 January 2016.
19. Johnson L. Access to antiretroviral treatment in South Africa, 2004-2011. South Afr J HIV Med 2012; 13:22-7.
20. Global report: UNAIDS report on the global AIDS epidemic 2013. Available at: http://www.unaids.org/sites/default/files/media-asset/UNAIDS-Global-Report-2013-en-1.pdf. Accessed 2 February 2015.
21. Madhi SA, Bamford L, Ngcobo N. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. S Afr Med J 2014; 104(3 suppl 1):228-34.
22. Mapaseka SL, Dewar JB, van der Merwe L, et al. Prospective hospital-based surveillance to estimate rotavirus disease burden in the Gauteng and North West Province of South Africa during 2003-2005. J Infect Dis 2010; 202(suppl): S131-8.
23. Steele AD, Peenze I, de Beer MC, et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine 2003; 21:354-60.
24. Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011; 29:4663-7.
25. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6.
26. Steele AD, Madhi SA, Louw CE, et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatr Infect Dis J 2011; 30:125-30.
27. National Department of Health, South Africa. Guidelines for the management of HIV in children, 2nd ed, 2010. Available at: http://www.sahivsoc.org/practiseguidelines/national-dept-of-health-guidelines. Accessed 13 January 2016.
28. National Department of Health, South Africa. The South African antiretroviral treatment guidelines, 2013. Available at: http://www.sahivsoc.org/practiseguidelines/national-dept-of-health-guidelines. Accessed 13 January 2016.
29. Statistics South Africa (STATSSA). Census 2011 municipal report-Gauteng. Pretoria: Statistics South Africa, 2012.